21st Asia-Pacific Prostate Cancer Conference
apc
10/15/20, 8:00 PM
Oceania/Australia AEST +10
Description
17:00
15 October 2020
Women in Urology
Notes
Favourite
Session - Clinical Urology - 120.0 mins - Room 01
We are excited to introduce our inaugural ‘Woman in Urology’ event as part of the APCC 2020. Despite increases in the number of women in urology worldwide, women are still vastly underrepresented in our specialty. In this session we hope to highlight the importance of increased female representation in urology, discuss the difficulties faced, the importance of leadership, and lessons learned from these outstanding surgeons to inspire all of those with an interest in the future of urology regardless of gender.
We are delighted to have international speakers, Professor Stacy Loeb and Professor Kirsten Greene, and Australian speakers, Dr Caroline Dowling, Dr Lydia Johns- Putra and Dr Renu Eapen.
Join us for this live, with the opportunity to ask questions to this fantastic panel. Dr Briony Norris and Dr Sandra Elmer will moderate this must attend session.
17:00
Welcome to APCC’s 'Women in Urology’
Notes
Favourite
17:05
Women in Urology: From the Perspective of Training in Australia and New Zealand
Dr Lydia Johns Putra - Ballarat Urology
Notes
Favourite
17:20
Representation of Women at Conferences and the Importance of Fellowship
Dr Renu Eapen - Peter MacCallum Cancer Centre
Notes
Favourite
17:35
Women in Urology and Leveraging Social Media
Prof Stacy Loeb - New York University School of Medicine
Notes
Favourite
17:50
Making the Next Step: Challenges Facing Women Leaders in Urology
Dr Caroline Dowling - Eastern Health
Notes
Favourite
18:05
Female Representation in Uro-oncology and Senior Faculty Roles in the United States
Prof Kirsten Greene - UVA Health
Notes
Favourite
18:20
Live Question and Answer - Moderated by Dr Briony Norris and Dr Sandra Elmer
Notes
Favourite
22:00
15 October 2020
PSMA-PET - Diagnostics, Theranostics & An Update on Australian studies
Notes
Favourite
Session - Clinical Urology, Translational Science - 120.0 mins - Room 01
PSMA-PET presents the most exciting tool for the diagnosis and treatment of prostate cancer in many years. This session explores the cutting edge of diagnostics and theranostics with the specialists at the forefront. The first talk outlines the importance of standardised reporting – why we get false positives and false negatives and how to avoid inaccurate results. A series of world-first papers emanating from Australia are then discussed – from the staging of metastatic disease (Pro-PSMA study) to the evaluation of the cancer within the prostate (PRIMARY study), to the futuristic treatment of prostate cancer using Lutetium-PSMA for both advanced and localised disease.
This session is proudly supported by AstraZeneca
22:00
Interrogating the interrogator! How do we standardise PSMA PET reporting? What does the Urologist need?
Professor Michael Hofman - Peter MacCallum Cancer Centre, Associate Professor Daniel Moon - Peter MacCallum Cancer Centre
Notes
Favourite
22:20
Results of the ProPSMA trial: Developing a new gold standard
Professor Michael Hofman - Peter MacCallum Cancer Centre
Notes
Favourite
22:40
COFFEE BREAK - PROUDLY SUPPORTED BY AstraZeneca
A chance to connect with our sponsors
Notes
Favourite
22:50
Should PSMA-PET be performed pre-biopsy? Results of PRIMARY
Professor Louise Emmett - St Vincent's Hospital Sydney
Notes
Favourite
23:10
Theranostic Opportunities
Professor Michael Hofman - Peter MacCallum Cancer Centre
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Briony Norris, Sandra Elmer
Women in Urology, PSMA-PET - Diagnostics, Theranostics & An Update on Australian studies, Watch Thursday Presentations on Demand
Inglês
Speakers
Lydia Johns Putra, Renu Eapen, Stacy Loeb, Caroline Hunt-Smith, Kirsten Greene, Michael Hofman, Louise Emmett
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.